🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the substance there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Elimination

According to the social media company, the service has taken down problematic content and banned related hashtags and search suggestions. The organization said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Trading Operations

Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, glowing testimonials and step-by-step instructions for mixing or injecting at residence.

Within moments of entering one community, a seller shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Product Information and Pricing

Inside these communities, messages display dark colored packages with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious health risks”.